Loading company…
Valencia, US medical device company developing an investigational Neuroimmune Modulation platform for chronic autoimmune diseases.
Founded in 2007 and headquartered in Valencia, US, SetPoint Medical Corporation develops treatments based on its proprietary Neuroimmune Modulation technology, which uses targeted electrical stimulation to regulate inflammation in chronic autoimmune diseases. Its core product is an investigational medical device. CEO Murthy Simhambhatla leads the company, which raised USD 115.00 mn in Series D funding in March 2025 and has completed 15 deals, the most recent on March 27, 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in